Related Experiment Video
Updated: Jan 11, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Decision-Making for Pediatric and Adolescent/Young Adult (AYA) Cancer Clinical Trials: An Integrative Review of
Anna Sparrow1, Michelle Kelly1, Jennifer Yost1
1M. Louise Fitzpatrick College of Nursing, Villanova University, Villanova, PA, USA.
Insights
Financial and logistical barriers significantly impact pediatric and adolescent/young adult cancer clinical trial participation. Addressing these issues through improved financial aid and decentralized trials is key to promoting equitable access for young cancer patients.
Area of Science:
- Oncology
- Clinical Trials
- Health Disparities
Background:
- Pediatric cancer clinical trial participation is crucial for advancing care but shows disparities.
- Understanding decision-making factors is essential for equitable involvement.
- Qualitative studies are vital for exploring patient and family experiences.
Purpose of the Study:
- To synthesize qualitative research on factors influencing pediatric and adolescent/young adult (AYA) cancer clinical trial participation.
- To identify gaps in current understanding and propose strategies for equitable involvement.
- To inform policy and practice for improved clinical trial access.
Main Methods:
- Integrative review using Whittemore and Knafl's methodology.
- Searches across major databases (PubMed, Scopus, CINAHL, Medline, Web of Science) from 2010-2024.
- Qualitative or mixed-methods, U.S.-based studies assessed with CASP checklist; thematic analysis.
Main Results:
- Seven studies met inclusion criteria, identifying systemic, interpersonal, and individual decision-making factors.
- Key themes included finances, logistics, communication, relationships, emotional distress, and perceived benefit.
- Financial burdens, logistical challenges, and communication barriers were prominent obstacles.
Conclusions:
- Actionable strategies include expanding financial assistance, decentralizing trials, and using structured communication tools.
- Addressing these barriers can improve access and support informed decision-making for pediatric and AYA cancer patients.
- Further research needed on patients not offered trials and intervention impacts for equitable strategies.
Abstract:
Background: Cancer clinical trials are critical to advancing pediatric oncology care, but participation varies across age and sociodemographic groups. Understanding decision-making factors influencing pediatric and adolescent/young adult (AYA) participation is essential to addressing these disparities. This integrative review synthesizes qualitative studies to explore decision-making factors affecting participation in cancer clinical trials, identify gaps, and propose strategies to promote equitable involvement. Method: Using Whittemore and Knafl's integrative review methodology, comprehensive searches were conducted in PubMed, Scopus, CINAHL, Medline, and Web of Science, with additional studies identified through ancestral searching. Included studies were qualitative or mixed-methods, U.S.-based, and published from 2010 to 2024. Methodological quality was assessed using the Critical Appraisal Skills Programme (CASP) checklist, and thematic patterns were analyzed through constant comparison and qualitative synthesis tools. Results: Seven studies met inclusion criteria. Systemic, interpersonal, and individual factors were identified as influential in decision-making. Key themes influencing participation included finances and logistics, communication, relationships, role responsibilities, emotional distress, and perceived benefit. Discussion: Financial burdens, logistical challenges, and communication barriers emerge as major actionable obstacles. Expanding financial assistance programs, decentralizing trials, and implementing structured communication tools can improve access and support informed decision-making. Future research should explore the experiences of patients who were never offered a trial and assess the impact of financial and logistical support interventions to develop more equitable and effective enrollment and outreach strategies. Addressing these barriers through targeted policy and practice changes can create a more accessible clinical trial landscape for pediatric and AYA patients with cancer.
Related Concept Videos
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Survival Analysis

